Clinical TrialsSearch results
Number of results: 659
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Phase II study of VAC1.2/VI therapy for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.
- rhabdomyosarcoma
- Miyachi Mitsuru
- 2019-03-26
Recruiting
- Phase II study of VAC2.2/VI therapy for patients with newly diagnosed
intermediate rhabdomyosarcoma
- Rhabdomyosarcoma
- Hosono Ako
- 2019-03-27
Completed
- Clinical trial of TK-98 on retinitis pigmentosa: A prospective, randomized, double-blind, placebo-controlled study
- retinitis pigmentosa
- Ikeda Hanako
- 2019-02-22
Completed
- Endovascular cannulation with a microneedle for RVO or RAO
- Retinal vein occlusion and retinal artery occlusion
- Kojima Kentaro
- 2019-05-21
Other
- A Multicenter Randomized Controlled Trial to Evaluate the Effect of Adjuvant Chemotherapy using Gemcitabine After Resection of Pancreatic Cancer
- resectable pancreatic cancer
- Study Group for Adjuvant Chemotherapy of Pancreatic Cancer
- 2005-08-05
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment (MagnetisMM-9)
- relapsed/refractory multiple myeloma
- Kawai Norisuke
- 2021-10-11
Other
- Phase II Study of Docetaxel and TS-1 Combination Therapy for Outpatients with Relapsed or Refractory Non-small Cell Lung cancer
- Relapsed or Refractory Non-small Cell Lung Cancer
- Outpatient Oncology Unit Kyoto University Hospital
- 2006-10-12